14 results
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
Diabetic Peripheral ... complication of diabetes ... clinic patients should ... Peripheral #Neuropathy #Diabetes ... #Pharmacology #
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... risks, and therapy should ... table #comparison #management ... #medications #diabetes
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... patients with Type 1 diabetes ... or Type 2 diabetes ... evidence-based pharmacologic ... #Diabetes #CKD #
Lyrica (Pregabalin) 
Indications: Neuropathy (diabetic, postherpetic neuralgia, fibromyalgia, & spinal cord injury), Adjunctive therapy for partial-onset
Indications: Neuropathy (diabetic ... partial-onset seizures Dosing ... pain (including diabetic ... Patients mood should ... Lyrica #Pregabalin #Pharmacology
IDSA - Diabetic Foot Infections - Suggested Route, Setting, and Duration of Antibiotic Therapy, by Clinical
IDSA - Diabetic ... postoperatively ≥3 mo #IDSA ... #Diabetic #Foot ... #antibiotics #pharmacology ... #management
IDSA Diabetic Foot infection - In Which Situations Is Diagnostic Bone Biopsy Most Recommended?
 • Patient
IDSA Diabetic Foot ... inflammatory markers during ... directed therapy (should ... metalware #IDSA ... #Diabetic #Foot
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... Inhibitors #Renal #Dosing ... #Pharmacology # ... Management #Diabetes
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... isolate DST result should ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... Patients should ... been shown non-inferior ... #semaglutide #Diabetes ... #Pharmacology #
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... best prevented by using ... CMV retinitis should ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology